Img Wealth Management, Inc. Macrogenics Inc Transaction History
Img Wealth Management, Inc.
- $129 Billion
- Q2 2025
A detailed history of Img Wealth Management, Inc. transactions in Macrogenics Inc stock. As of the latest transaction made, Img Wealth Management, Inc. holds 1,150 shares of MGNX stock, worth $1,955. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,150
Previous 1,150
-0.0%
Holding current value
$1,955
Previous $1.46 Million
4.72%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding MGNX
# of Institutions
119Shares Held
52.3MCall Options Held
55.3KPut Options Held
35.9K-
Bellevue Group Ag Kuesnacht, V89.92MShares$16.9 Million0.27% of portfolio
-
Armistice Capital, LLC New York, NY5.96MShares$10.1 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$9.18 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.21MShares$7.16 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$5.53 Million0.02% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $104M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...